<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Epilepsia Open</journal-id><journal-id journal-id-type="iso-abbrev">Epilepsia Open</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2470-9239</journal-id><journal-id journal-id-type="publisher-id">EPI4</journal-id><journal-title-group><journal-title>Epilepsia Open</journal-title></journal-title-group><issn pub-type="epub">2470-9239</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29588936</article-id><article-id pub-id-type="pmc">5719830</article-id><article-id pub-id-type="doi">10.1002/epi4.12020</article-id><article-id pub-id-type="publisher-id">EPI412020</article-id><article-categories><subj-group subj-group-type="overline"><subject>Full&#x02010;Length Original Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Full&#x02010;length Original Research</subject></subj-group></article-categories><title-group><article-title>Cathodal transcranial direct&#x02010;current stimulation for treatment of drug&#x02010;resistant temporal lobe epilepsy: A pilot randomized controlled trial</article-title><alt-title alt-title-type="left-running-head">M. Zoghi et&#x000a0;al.</alt-title></title-group><contrib-group><contrib id="epi412020-cr-0001" contrib-type="author" corresp="yes"><name><surname>Zoghi</surname><given-names>Maryam</given-names></name><address><email>mzoghi@unimelb.edu.au</email></address><xref ref-type="aff" rid="epi412020-aff-0001">
<sup>1</sup>
</xref><xref ref-type="bio" rid="epi412020-biog-0001">*</xref></contrib><contrib id="epi412020-cr-0002" contrib-type="author"><name><surname>O'Brien</surname><given-names>Terence J.</given-names></name><xref ref-type="aff" rid="epi412020-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="epi412020-cr-0003" contrib-type="author"><name><surname>Kwan</surname><given-names>Patrick</given-names></name><xref ref-type="aff" rid="epi412020-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="epi412020-cr-0004" contrib-type="author"><name><surname>Cook</surname><given-names>Mark J.</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8875-4135</contrib-id><xref ref-type="aff" rid="epi412020-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="epi412020-cr-0005" contrib-type="author"><name><surname>Galea</surname><given-names>Mary</given-names></name><xref ref-type="aff" rid="epi412020-aff-0003">
<sup>3</sup>
</xref></contrib><contrib id="epi412020-cr-0006" contrib-type="author"><name><surname>Jaberzadeh</surname><given-names>Shapour</given-names></name><xref ref-type="aff" rid="epi412020-aff-0004">
<sup>4</sup>
</xref></contrib></contrib-group><aff id="epi412020-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Medicine</named-content>
<named-content content-type="organisation-division">The Royal Melbourne Hospital</named-content>
<institution>The University of Melbourne</institution>
<named-content content-type="city">Parkville</named-content>
<named-content content-type="country-part">Victoria</named-content>
<country country="AU">Australia</country>
</aff><aff id="epi412020-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Medicine</named-content>
<named-content content-type="organisation-division">St Vincent's Hospital</named-content>
<institution>The University of Melbourne</institution>
<named-content content-type="city">Fitzroy</named-content>
<named-content content-type="country-part">Victoria</named-content>
<country country="AU">Australia</country>
</aff><aff id="epi412020-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Department of Medicine</named-content>
<named-content content-type="organisation-division">The Royal Melbourne Hospital (Royal Park Campus)</named-content>
<institution>The University of Melbourne</institution>
<named-content content-type="city">Parkville</named-content>
<named-content content-type="country-part">Victoria</named-content>
<country country="AU">Australia</country>
</aff><aff id="epi412020-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">School of Primary Health Care</named-content>
<named-content content-type="organisation-division">Faculty of Medicine, Nursing and Health Sciences</named-content>
<institution>Monash University</institution>
<named-content content-type="city">Frankston</named-content>
<named-content content-type="country-part">Victoria</named-content>
<country country="AU">Australia</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label>Address correspondence to Maryam Zoghi, Department of Medicine, Royal Melbourne Hospital, The University of Melbourne, 4th Floor, Clinical Sciences Building, 300 Grattan Street, Parkville, Vic. 3052, Australia. E&#x02010;mail: <email>mzoghi@unimelb.edu.au</email></corresp></author-notes><pub-date pub-type="epub"><day>17</day><month>10</month><year>2016</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2016</year></pub-date><volume>1</volume><issue>3-4</issue><issue-id pub-id-type="doi">10.1002/epi4.2016.1.issue-3pt4</issue-id><fpage>130</fpage><lpage>135</lpage><history><date date-type="accepted"><day>16</day><month>8</month><year>2016</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2016 International League Against Epilepsy <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2016 The Authors. <italic>Epilepsia Open</italic> published by Wiley Periodicals Inc. on behalf of International League Against Epilepsy.</copyright-statement><license license-type="creativeCommonsBy-nc-nd"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution&#x02010;NonCommercial&#x02010;NoDerivs</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non&#x02010;commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:EPI4-1-130.pdf"/><abstract id="epi412020-abs-0001"><title>Summary</title><sec id="epi412020-sec-0001"><title>Objective</title><p>To investigate the effect of cathodal transcranial direct&#x02010;current stimulation (c&#x02010;t<styled-content style="fixed-case">DCS</styled-content>) on seizure frequency in patients with drug&#x02010;resistant temporal lobe epilepsy (<styled-content style="fixed-case">TLE</styled-content>).</p></sec><sec id="epi412020-sec-0002"><title>Method</title><p>Twenty&#x02010;nine patients with drug&#x02010;resistant <styled-content style="fixed-case">TLE</styled-content> participated in this study. They were randomized to experimental or sham group. Twenty participants (experimental group) received within&#x02010;session repeated c&#x02010;t<styled-content style="fixed-case">DCS</styled-content> intervention over the affected temporal lobe, and nine (sham group) received sham t<styled-content style="fixed-case">DCS</styled-content>. Paired&#x02010;pulse transcranial magnetic stimulation was used to assess short interval intracortical inhibition (<styled-content style="fixed-case">SICI</styled-content>) in primary motor cortex ipsilateral to the affected temporal lobe. <styled-content style="fixed-case">SICI</styled-content> was measured from motor evoked potentials recorded from the contralateral first dorsal interosseous muscle. Adverse effects were monitored during and after each intervention in both groups. A seizure diary was given to each participant to complete for 4&#x000a0;weeks following the t<styled-content style="fixed-case">DCS</styled-content> intervention. The mean response ratio was calculated from their seizure rates before and after the t<styled-content style="fixed-case">DCS</styled-content> intervention.</p></sec><sec id="epi412020-sec-0003"><title>Results</title><p>The experimental group showed a significant increase in <styled-content style="fixed-case">SICI</styled-content> compared to the sham group (F&#x000a0;=&#x000a0;10.3, p&#x000a0;=&#x000a0;0.005). None of the participants reported side effects of moderate or severe degree. The mean response ratio in seizure frequency was &#x02212;42.14% (standard deviation [<styled-content style="fixed-case">SD</styled-content>] 35.93) for the experimental group and &#x02212;16.98% (<styled-content style="fixed-case">SD</styled-content> 52.41) for the sham group.</p></sec><sec id="epi412020-sec-0004"><title>Significance</title><p>Results from this pilot study suggest that t<styled-content style="fixed-case">DCS</styled-content> may be a safe and efficacious nonpharmacologic intervention for patients with drug&#x02010;resistant <styled-content style="fixed-case">TLE</styled-content>. Further evaluation in larger double&#x02010;blind randomized controlled trials is warranted.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="epi412020-kwd-0001">Cathodal transcranial direct&#x02010;current stimulation</kwd><kwd id="epi412020-kwd-0002">Drug resistant</kwd><kwd id="epi412020-kwd-0003">Temporal lobe epilepsy</kwd></kwd-group><counts><fig-count count="3"/><table-count count="2"/><page-count count="6"/><word-count count="4328"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>epi412020</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>December 2016</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.2.5 mode:remove_FC converted:17.11.2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>
<boxed-text position="anchor" content-type="box" id="epi412020-blkfxd-0001" orientation="portrait"><caption><title>Key Points</title></caption><p>
<list list-type="bullet" id="epi412020-list-0001"><list-item><p>Within&#x02010;session repeated (9&#x02010;20&#x02010;9 protocol) c&#x02010;tDCS has shown no or minimal side effects in patients with drug&#x02010;resistant temporal lobe epilepsy</p></list-item><list-item><p>Cortical excitability was reduced, as measured by SICI, after one application of c&#x02010;tDCS using the 9&#x02010;20&#x02010;9 protocol in patients with drug&#x02010;resistant temporal lobe epilepsy</p></list-item><list-item><p>Seizure rates reduced by 42% after one application of c&#x02010;tDCS using the 9&#x02010;20&#x02010;9 protocol in patients with drug&#x02010;resistant temporal lobe epilepsy</p></list-item></list>
</p></boxed-text>
</p><sec id="epi412020-sec-0006"><p>Epilepsy impacts 50&#x000a0;million people (1% of the population) worldwide.<xref rid="epi412020-bib-0001" ref-type="ref">1</xref> Management for patients with epilepsy includes antiepileptic drugs (AEDs), and for some patients with drug&#x02010;resistant seizures, surgery. Temporal lobe epilepsy (TLE) is often resistant to AEDs,<xref rid="epi412020-bib-0002" ref-type="ref">2</xref> and &#x0003e;40% of patients with epilepsy have adverse reactions to AEDs. Removing the epileptogenic regions surgically is not always feasible for patients, and the outcome is not ideal in 30&#x02013;50% of cases.<xref rid="epi412020-bib-0003" ref-type="ref">3</xref> Consequently, alternative methods of <italic>seizure control</italic> warrant more investigation.</p><p>The excitability of the &#x003b3;&#x02010;aminobutyric acid (GABA)ergic intracortical inhibitory circuits in primary motor cortex (M1) can be assessed noninvasively in humans by paired&#x02010;pulse transcranial magnetic stimulation (TMS). In this technique, two stimuli are delivered 1&#x02013;5&#x000a0;msec apart through the same coil. The first stimulus is subthreshold for a motor response; however, it activates intracortical inhibition (ICI) circuits and reduces the size of the motor evoked potentials (MEPs) elicited by the second stimulus, which is supra&#x02010;threshold for a motor response.<xref rid="epi412020-bib-0004" ref-type="ref">4</xref> It has been shown that ICI measured using this method reflects the cortical activity of GABAergic interneurons in the M1 area.<xref rid="epi412020-bib-0005" ref-type="ref">5</xref> This inhibition is termed short&#x02010;interval intracortical inhibition or SICI.</p><p>ICI circuits have been assessed extensively with a paired&#x02010;pulse paradigm in patients with epilepsy.<xref rid="epi412020-bib-0006" ref-type="ref">6</xref>, <xref rid="epi412020-bib-0007" ref-type="ref">7</xref>, <xref rid="epi412020-bib-0008" ref-type="ref">8</xref> Several studies on drug&#x02010;naive patients with focal epilepsy showed a decrease in SICI in the ipsilateral hemisphere.<xref rid="epi412020-bib-0009" ref-type="ref">9</xref>, <xref rid="epi412020-bib-0010" ref-type="ref">10</xref>, <xref rid="epi412020-bib-0011" ref-type="ref">11</xref>, <xref rid="epi412020-bib-0012" ref-type="ref">12</xref>, <xref rid="epi412020-bib-0013" ref-type="ref">13</xref>, <xref rid="epi412020-bib-0014" ref-type="ref">14</xref>, <xref rid="epi412020-bib-0015" ref-type="ref">15</xref> Badawy et&#x000a0;al. showed increased M1 excitability and decreased SICI in 35 patients with focal epilepsy 24&#x000a0;h before and after a seizure.</p><p>Transcranial direct current stimulation (tDCS) is a well&#x02010;established cortical stimulation method that can be used noninvasively to modulate neuronal excitability in humans.<xref rid="epi412020-bib-0016" ref-type="ref">16</xref> In this technique, a low intensity current (1&#x02013;2&#x000a0;mA) is used that can affect the membrane potentials in two ways. Cathodal tDCS (c&#x02010;tDCS) hyperpolarizes the resting membrane potentials, whereas anodal tDCS acts toward depolarization.<xref rid="epi412020-bib-0016" ref-type="ref">16</xref> Modification of seizure network excitability by tDCS is a potentially valuable noninvasive alternative for reducing the excitability of this abnormal network in patients with epilepsy and thereby reducing the seizure rates in this population.</p><p>The aim of this study was to examine the effects of this noninvasive therapeutic approach on seizure frequency in this group of patients. We hypothesized that compared to sham tDCS, application of c&#x02010;tDCS over the temporal lobe in patients with drug&#x02010;resistant TLE, decreases seizure frequency and increases intracortical inhibition in the ipsilateral M1 area.</p></sec><sec id="epi412020-sec-0007"><title>Method</title><sec id="epi412020-sec-0008"><title>Participants</title><p>We conducted a small pilot study in patients admitted to the video&#x02013;electroencephalography (EEG) monitoring (VEM) unit at the Royal Melbourne Hospital or as outpatients at St Vincent's Hospital. Twenty&#x02010;nine participants (11 male, 18 female) with drug&#x02010;resistant TLE and mean age of 38&#x000a0;&#x000b1;&#x000a0;13 (SD) participated in this study. All 24 participants from the Royal Melbourne Hospital were admitted as potential surgical candidates to the VEM unit. The etiology of the TLE varied between participants and included tumor, meningitis, infantile febrile, cortical dysplasia, and unknown reason. Inclusion criteria were the following: (1)&#x02265;18&#x000a0;years of age; (2) diagnosed with drug&#x02010;resistant TLE, as defined by the International League Against Epilepsy (failure to become [and stay] seizure&#x02010;free with adequate trials of two seizure medications); and (3) able to understand, speak, and write in English. Exclusion criteria were the following: (1) skin conditions (e.g., eczema, lesions) on scalp; (2) metal inside the head (outside the mouth) such as shrapnel, surgical clips; (3) any implanted devices such as cardiac pacemaker, cochlear implant, medical pump, or intracardiac line; (4) frequent or severe headaches; (5) previous head injury and any other brain&#x02010;related disease; and (6) pregnancy and breastfeeding. All procedures used in this study conformed with the Declaration of Helsinki, and the protocol was approved by the Human Research Ethics Committees at The University of Melbourne and Melbourne Health. Written informed consent was obtained from each participant.</p></sec><sec id="epi412020-sec-0009"><title>Intervention</title><p>One session of c&#x02010;tDCS or sham tDCS (9&#x02010;20&#x02010;9 protocol) was applied in the last day of each participants&#x02019; admission in the VEM unit at the Royal Melbourne Hospital (RMH) or in a quiet room at St Vincent's Hospital as an outpatient. Participants were randomly allocated to experimental or sham group. They were all blinded to the nature of the intervention (experimental vs. sham). This protocol involved a total of 18&#x000a0;min c&#x02010;tDCS or sham tDCS, with 20&#x000a0;min rest after the first 9&#x000a0;min (Fig.&#x000a0;<xref rid="epi412020-fig-0001" ref-type="fig">1</xref>). A DC&#x02010;Stimulator (Chattanooga Intelect Advanced Combo) was used to deliver a 1&#x000a0;mA continuous galvanic current to the brain via two surface electrodes with surrounding saline&#x02010;soaked sponges (0.9% NaCl). The active surface electrode (cathode, 3&#x000a0;&#x000d7;&#x000a0;4&#x000a0;cm) was placed over the affected temporal lobe, and the return electrode<xref rid="epi412020-bib-0017" ref-type="ref">17</xref> (anode, 5&#x000a0;&#x000d7;&#x000a0;7&#x000a0;cm) was placed over the contralateral supraorbital area.</p><fig fig-type="Figure" xml:lang="en" id="epi412020-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Experimental set&#x02010;up. All participants received one session of c&#x02010;t<styled-content style="fixed-case">DCS</styled-content> or sham t<styled-content style="fixed-case">DCS</styled-content> paradigm (9&#x02010;20&#x02010;9 protocol). The active surface electrode (cathode) was placed over the temporal lobe in the affected hemisphere. The return (anode) electrode was placed over the supraorbital area contralateral to the stimulated hemisphere. <styled-content style="fixed-case">SICI</styled-content> was assessed before and after t<styled-content style="fixed-case">DCS</styled-content> intervention. Seizure rates were recorded for 4&#x000a0;weeks after t<styled-content style="fixed-case">DCS</styled-content> intervention.</p></caption><graphic id="nlm-graphic-3" xlink:href="EPI4-1-130-g001"/></fig></sec><sec id="epi412020-sec-0010"><title>Assessment</title><p>Participants were asked to keep a record of their seizures in a daily seizure diary for 4&#x000a0;weeks after the intervention. The mean response ratio was calculated by the following formula: [(T&#x02212;B)/(T&#x000a0;+&#x000a0;B)]&#x000a0;&#x000d7;&#x000a0;100. In this formula, B is the patient's baseline seizure frequency over the 4&#x000a0;weeks prior to treatment, and T is the patient's seizure frequency in the 4&#x000a0;weeks after the treatment. In this study, the seizure rate prior the intervention for each participant was recorded based on participant's report. Negative response ratio values indicate reduced seizure rate from baseline. The response ratio allows for a normalized percentage change in seizure rate from baseline, with values within the range of &#x02212;100 to +100. Zero value in this range indicates no change.<xref rid="epi412020-bib-0018" ref-type="ref">18</xref>
</p><p>Paired&#x02010;pulse TMS (Magstim BiStim<sup>2</sup>) was used to assess SICI before and after each intervention. Participants were seated with head and neck supported by a headrest. MEPs were recorded from the first dorsal interosseous (FDI) muscle before and after each intervention. Resting threshold (RT) for recording MEPs was defined as the lowest intensity to record three of five successive MEPs &#x0003e;50&#x000a0;&#x003bc;V (peak&#x02010;to&#x02010;peak amplitude) from FDI. The TMS intensity for the supra&#x02010;threshold stimuli was adjusted to produce MEPs in FDI at rest of about 1&#x000a0;mV amplitude (test intensity). The TMS intensity for the sub&#x02010;threshold stimuli was adjusted to 0.8&#x000a0;&#x000d7;&#x000a0;RT (conditioning intensity) with 3&#x000a0;msec interstimulus interval. Single or paired&#x02010;pulse TMS was delivered in blocks of 20 stimuli (10&#x000a0;s interval between stimuli) at rest (40 trials at each session).</p><p>Adverse events related to the application of c&#x02010;tDCS (e.g., itching, tingling, burning sensation; headache, neck pain, etc.) in this study were assessed using the Adverse Effects Questionnaire<xref rid="epi412020-bib-0019" ref-type="ref">19</xref> during and after each session.</p></sec></sec><sec id="epi412020-sec-0011"><title>Results</title><p>All participants tolerated the intervention very well. None of the participants reported side effects of moderate or severe degree during or after the intervention. A few participants reported itching sensations (2/10) for few minutes under the anode electrode. Twenty&#x02010;three participants returned their diaries (Table&#x000a0;<xref rid="epi412020-tbl-0001" ref-type="table-wrap">1</xref>). The mean response ratio was calculated from their seizure rates before and after the tDCS intervention (Table&#x000a0;<xref rid="epi412020-tbl-0002" ref-type="table-wrap">2</xref>). The mean response ratio was &#x02212;42.14% (standard deviation [SD] 35.93) for the experimental group and &#x02212;16.98% (SD 52.41) for the sham group. SICI was measured with paired&#x02010;pulse TMS (Magstim BiStim<xref rid="epi412020-bib-0002" ref-type="ref">2</xref>
<bold>)</bold> before and after the tDCS intervention in 17 participants (Table&#x000a0;<xref rid="epi412020-tbl-0001" ref-type="table-wrap">1</xref>).</p><table-wrap id="epi412020-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>Distribution of collected data in participants</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Group</th><th align="center" valign="top" rowspan="1" colspan="1">Number of participants</th><th align="center" valign="top" rowspan="1" colspan="1">TMS data collected</th><th align="center" valign="top" rowspan="1" colspan="1">Seizure diary returned</th><th align="center" valign="top" rowspan="1" colspan="1">No TMS data collected/no seizure diary returned</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Experimental</td><td align="char" char="." rowspan="1" colspan="1">20</td><td align="char" char="." rowspan="1" colspan="1">12</td><td align="char" char="." rowspan="1" colspan="1">16</td><td align="char" char="." rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">Sham</td><td align="char" char="." rowspan="1" colspan="1">9</td><td align="char" char="." rowspan="1" colspan="1">5</td><td align="char" char="." rowspan="1" colspan="1">7</td><td align="char" char="." rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">Total</td><td align="char" char="." rowspan="1" colspan="1">29</td><td align="char" char="." rowspan="1" colspan="1">17</td><td align="char" char="." rowspan="1" colspan="1">23</td><td align="char" char="." rowspan="1" colspan="1">5</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><table-wrap id="epi412020-tbl-0002" xml:lang="en" orientation="portrait" position="float"><label>Table 2</label><caption><p>Seizure rates in experimental group versus sham group before and after t<styled-content style="fixed-case">DCS</styled-content> intervention and mean response ratio in both groups</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Group</th><th align="center" valign="top" rowspan="1" colspan="1">Seizure diary returned</th><th align="center" valign="top" rowspan="1" colspan="1">Seizure rate before tDCS&#x000a0;&#x000b1;&#x000a0;SD</th><th align="center" valign="top" rowspan="1" colspan="1">Seizure rate after tDCS&#x000a0;&#x000b1;&#x000a0;SD</th><th align="center" valign="top" rowspan="1" colspan="1">Mean response ratio [(T&#x02212;B)/(T&#x000a0;+&#x000a0;B)]&#x000a0;&#x000d7;&#x000a0;100</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Experimental</td><td align="char" char="." rowspan="1" colspan="1">16</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">53&#x000a0;&#x000b1;&#x000a0;78.95</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">17.18&#x000a0;&#x000b1;&#x000a0;26.03</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">&#x02212;42.14&#x000a0;&#x000b1;&#x000a0;35.93</td></tr><tr><td align="left" rowspan="1" colspan="1">Sham</td><td align="char" char="." rowspan="1" colspan="1">7</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">20.28&#x000a0;&#x000b1;&#x000a0;33.69</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">13&#x000a0;&#x000b1;&#x000a0;16.2</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">&#x02212;16.98&#x000a0;&#x000b1;&#x000a0;52.41</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><p>One&#x02010;way analysis of variance (ANOVA) showed that SICI was increased significantly in the experimental group compared to the sham group (F&#x000a0;=&#x000a0;10.3, p&#x000a0;=&#x000a0;0.005) (Fig.&#x000a0;<xref rid="epi412020-fig-0002" ref-type="fig">2</xref>). The individual SICI level before and after c&#x02010;tDCS can be seen in Figure&#x000a0;<xref rid="epi412020-fig-0003" ref-type="fig">3</xref>.</p><fig fig-type="Figure" xml:lang="en" id="epi412020-fig-0002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Mean <styled-content style="fixed-case">SICI</styled-content> changes post c&#x02010;t<styled-content style="fixed-case">DCS</styled-content> versus sham t<styled-content style="fixed-case">DCS</styled-content>. The <styled-content style="fixed-case">MEP</styled-content>s were recorded from the first dorsal interosseous (<styled-content style="fixed-case">FDI</styled-content>) muscle. The area of the conditioned and unconditioned <styled-content style="fixed-case">MEP</styled-content>s were measured from the averaged rectified <styled-content style="fixed-case">MEP</styled-content>s obtained in each trial. The size of the conditioned <styled-content style="fixed-case">MEP</styled-content>s was expressed as a percentage of the unconditioned test <styled-content style="fixed-case">MEP</styled-content>s in order to assess the effectiveness of <styled-content style="fixed-case">SICI</styled-content>. <styled-content style="fixed-case">SICI</styled-content> was increased significantly in the experimental group compared to the sham group (F&#x000a0;=&#x000a0;10.3, p&#x000a0;=&#x000a0;0.005).</p></caption><graphic id="nlm-graphic-5" xlink:href="EPI4-1-130-g002"/></fig><fig fig-type="Figure" xml:lang="en" id="epi412020-fig-0003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Individual <styled-content style="fixed-case">SICI</styled-content> changes post c&#x02010;t<styled-content style="fixed-case">DCS</styled-content> or sham t<styled-content style="fixed-case">DCS</styled-content>. <styled-content style="fixed-case">SICI</styled-content> changes post c&#x02010;t<styled-content style="fixed-case">DCS</styled-content> (<bold>A</bold>) or sham t<styled-content style="fixed-case">DCS</styled-content> (<bold>B</bold>) for each participant. Blue circles show <styled-content style="fixed-case">SICI</styled-content> level at baseline. Full triangles or rectangles show <styled-content style="fixed-case">SICI</styled-content> level post t<styled-content style="fixed-case">DCS</styled-content>. In <bold>A</bold>, most participants show a trend of increased <styled-content style="fixed-case">SICI</styled-content> post c&#x02010;t<styled-content style="fixed-case">DCS</styled-content>. In <bold>B</bold>, no trend of increased <styled-content style="fixed-case">SICI</styled-content> is seen in any participant.</p></caption><graphic id="nlm-graphic-7" xlink:href="EPI4-1-130-g003"/></fig></sec><sec id="epi412020-sec-0012"><title>Discussion</title><p>This pilot study showed that c&#x02010;tDCS using the 9&#x02010;20&#x02010;9 protocol could not only increase SICI, but also decrease seizure rates in patients with drug&#x02010;resistant TLE. The results of this pilot study cannot be compared to those of previous studies, since no SICI data are available post c&#x02010;tDCS and this new protocol (9&#x02010;20&#x02010;9) has not been applied previously to patients with drug&#x02010;resistant epilepsy.</p><p>Regardless of the cause of epilepsy, it has been argued that seizure networks are highly excitable as a result of unbalanced neuronal excitatory/inhibitory networks within the affected region.<xref rid="epi412020-bib-0020" ref-type="ref">20</xref> Therefore, the main aim in seizure control is manipulating these networks in such a way that the seizure networks remain in a &#x0201c;sub&#x02010;threshold&#x0201d; condition and are not triggered. The excitatory/inhibitory networks can be manipulated by decreasing the excitability of the excitatory networks or increasing the function of inhibitory networks, or both at the same time.<xref rid="epi412020-bib-0021" ref-type="ref">21</xref> Drugs that block voltage&#x02010;dependent ion channels or excitatory <italic>N</italic>&#x02010;methyl&#x02010;<sc>d</sc>&#x02010;aspartate (NMDA) receptors, or enhance GABAergic activity have been shown to have a profound ability to suppress the development of seizures.<xref rid="epi412020-bib-0021" ref-type="ref">21</xref> Antiepileptic effects of c&#x02010;tDCS can be expected due to the fact that c&#x02010;tDCS decreases cortical excitability by hyperpolarizing the membrane potentials and subsequently altering synaptic efficacy.<xref rid="epi412020-bib-0022" ref-type="ref">22</xref>, <xref rid="epi412020-bib-0023" ref-type="ref">23</xref> Lang et&#x000a0;al.<xref rid="epi412020-bib-0024" ref-type="ref">24</xref> recorded corticospinal volleys evoked by single&#x02010;pulse TMS of M1 before and after a 5&#x02010;min period of c&#x02010;tDCS in eight conscious patients who had electrodes implanted in the cervical epidural space. They showed that c&#x02010;tDCS suppressed the excitability of cortical circuits generating later &#x0201c;indirect waves&#x0201d; (I waves) in the corticospinal system. They suggested that c&#x02010;tDCS facilitates inhibitory connections or it produces dis&#x02010;facilitation (e.g., hyperpolarization) of excitatory connections leading, to a selective suppression of later I waves.<xref rid="epi412020-bib-0024" ref-type="ref">24</xref> In a recent study Dhamne et&#x000a0;al.<xref rid="epi412020-bib-0025" ref-type="ref">25</xref> reported that 1&#x000a0;mA c&#x02010;tDCS for 20&#x000a0;min could reduce seizures, augment lorazepam efficacy, and enhance GABAergic cortical inhibition in kindled rats.</p><p>The effects of tDCS are strongly dependent on electrode montage and parameters of stimulation. It has been shown that the induced excitability changes and the length of the lasting effect depend on two parameters of direct currents: <italic>intensity</italic> and <italic>duration of application</italic>.<xref rid="epi412020-bib-0026" ref-type="ref">26</xref>, <xref rid="epi412020-bib-0027" ref-type="ref">27</xref> The effects of modifications of these parameters have been tested in a few clinical applications.<xref rid="epi412020-bib-0028" ref-type="ref">28</xref>, <xref rid="epi412020-bib-0029" ref-type="ref">29</xref>, <xref rid="epi412020-bib-0030" ref-type="ref">30</xref>
</p><p>Fregni et&#x000a0;al.<xref rid="epi412020-bib-0031" ref-type="ref">31</xref> studied the effects of c&#x02010;tDCS (one session, 20&#x000a0;min, 1&#x000a0;mA) in patients with drug&#x02010;resistant epilepsy and malformations of cortical development as indicated by seizure frequency and epileptiform EEG discharges. They applied the c&#x02010;tDCS over the epileptogenic focus, and showed that c&#x02010;tDCS could decrease cortical excitability in the epileptogenic focus of these patients. They also reported a trend (p&#x000a0;=&#x000a0;0.06) for decrease in seizure frequency after active c&#x02010;tDCS compared with sham treatment (mean seizure frequency decrease of &#x02212;44.0% for the active treatment group and &#x02212;11.1% for the sham treatment group). The seizure reduction rate was similar to that of the present study (&#x02212;42.14% in experimental group and &#x02212;16.98% in sham group).</p><p>Auvichayapat et&#x000a0;al.<xref rid="epi412020-bib-0032" ref-type="ref">32</xref> assessed the antiepileptic efficacy of c&#x02010;tDCS in 36 children (6&#x02010; to &#x02013;15&#x02010;years&#x02010;old) with drug&#x02010;resistant epilepsy. Twenty&#x02010;seven children in the active group received a single session c&#x02010;tDCS (1&#x000a0;mA) for 20&#x000a0;min, whereas the remainder were in a sham group. In the active group, c&#x02010;tDCS suppressed epileptiform discharges for 48&#x000a0;h, with a small (clinically negligible but statistically significant) decrease in seizure frequency. Faria et&#x000a0;al.<xref rid="epi412020-bib-0033" ref-type="ref">33</xref> applied c&#x02010;tDCS for 30&#x000a0;min with the same intensity in two children with drug&#x02010;resistant continuous spike&#x02010;wave discharges during slow sleep. They reported similar results in terms of safety and the efficacy of c&#x02010;tDCS in reduction of the interictal epileptiform EEG discharges. Varga et&#x000a0;al.,<xref rid="epi412020-bib-0034" ref-type="ref">34</xref> however, applied c&#x02010;tDCS before sleep on five patients with focal, drug&#x02010;resistant continuous spikes and waves during slow sleep with no effects on the spikes. The c&#x02010;tDCS parameters used were similar to those used in the Faria et&#x000a0;al. study except that the duration of treatment was 10&#x000a0;min shorter.<xref rid="epi412020-bib-0034" ref-type="ref">34</xref>
</p><p>Yook et&#x000a0;al.<xref rid="epi412020-bib-0035" ref-type="ref">35</xref> reported the results of c&#x02010;tDCS application in an 11&#x02010;year&#x02010;old girl with focal cortical dysplasia. This patient received c&#x02010;tDCS over the site where the abnormal wave was observed (through EEG recordings) for 20&#x000a0;min with 2&#x000a0;mA, 5&#x000a0;days per week for 2&#x000a0;weeks. During the 2&#x02010;month monitoring period after this treatment they reported that not only was the duration of the seizures decreased but also the frequency of her seizures reduced from eight seizures per month to three seizures per month. This protocol was reapplied for another 2&#x000a0;weeks, with only one seizure reported in the following 2&#x000a0;months.</p><p>Although all the tDCS protocols that have been used in the above&#x02010;mentioned clinical studies are well within safety limits,<xref rid="epi412020-bib-0036" ref-type="ref">36</xref> it is a general goal to keep current exposure as low as possible. High&#x02010;intensity stimulation can not only be painful,<xref rid="epi412020-bib-0037" ref-type="ref">37</xref> it also can affect different neuronal populations compared with low intensity stimulation. By increasing the intensity, the current may reach deeper sites that might not be the intended target.</p><p>One way to prolong the after&#x02010;effects of tDCS might be the repetition of tDCS sessions. Monte&#x02010;Silva et&#x000a0;al.<xref rid="epi412020-bib-0038" ref-type="ref">38</xref> showed that application of c&#x02010;tDCS for 18&#x000a0;min with a 20&#x000a0;min break after the first 9&#x000a0;min will increase the inhibitory effects of this technique for up to 2&#x000a0;h (9&#x02010;20&#x02010;9 protocol). This protocol was used in this pilot study in one session on patients with drug&#x02010;resistant TLE.</p><p>We had an opportunity to apply c&#x02010;tDCS with (9&#x02010;20&#x02010;9) protocol on two consecutive days in a 48&#x02010;year&#x02010;old woman with drug&#x02010;resistant TLE while she was admitted to VEM unit at RMH.<xref rid="epi412020-bib-0039" ref-type="ref">39</xref> She had a right frontotemporal pleomorphic astrocytoma for 10&#x000a0;years with 5&#x02013;10 seizures per day. After receiving the c&#x02010;tDCS on the last 2&#x000a0;days of her admission, she reported a seizure reduction of 0&#x02013;3 seizures per day over a 4&#x000a0;month period. These observations suggest that c&#x02010;tDCS might have accumulative inhibitory effects on the abnormal epileptic networks.</p><p>A recent review of the effect of c&#x02010;tDCS on epilepsy assessed nine original studies (three animal, six human) up to 2014.<xref rid="epi412020-bib-0040" ref-type="ref">40</xref> In these studies, 109 animals and 65 humans received c&#x02010;tDCS with different parameters (including electrode montage, size of the electrodes, and duration and intensity of the applied c&#x02010;tDCS). Because of the different methods of c&#x02010;tDCS application, and the lack of long&#x02010;term follow&#x02010;up, only preliminary evidence of the safety and efficacy of this technique in controlling seizures in animals and patients with epilepsy could be concluded.<xref rid="epi412020-bib-0040" ref-type="ref">40</xref>
</p><sec id="epi412020-sec-0013"><title>Limitations</title><p>We acknowledge the limitations of this pilot study (open label, unequal groups). However, the results are encouraging. The results of this pilot study should be interpreted with caution. Even though all participants were diagnosed with drug&#x02010;resistant TLE, they were not homogenous in regards to the etiology, onset of their epilepsy, or the seizure rates. The seizure rate changes were measured based on baseline seizure rates that were reported by patients. TMS assessment could not be done on all participants due to unforeseen reasons (e.g., time constraint due to being scheduled for other assessments before they were discharged, unavailability of the device and so on).</p></sec><sec id="epi412020-sec-0014"><title>Future directions</title><p>This novel technique (tDCS) has, to date, shown no or minimal side effects, and it can be applied by an inexpensive battery&#x02010;operated device. This new technique should be assessed in a large randomized double&#x02010;blind controlled trial. If successful, it has the potential to be readily translated into clinical practice as a safe and well&#x02010;tolerated non&#x02010;medical treatment option for epilepsy management. In this way, patients may be able to control their seizures without the side effects associated with taking additional AEDs.</p></sec></sec><sec id="epi412020-sec-0015"><title>Disclosure</title><p>None of the authors has any conflict of interest to disclose. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.</p></sec></body><back><bio id="epi412020-biog-0001"><p>
<bold>Dr. Maryam Zoghi</bold> is a senior neuroscientist based at Royal Melbourne Hospital, The University of Melbourne.</p><graphic xlink:href="EPI4-1-130-g004.gif" position="anchor" id="nlm-graphic-1" orientation="portrait"/></bio><ref-list content-type="cited-references" id="epi412020-bibl-0001"><title>References</title><ref id="epi412020-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="epi412020-cit-0001">
<string-name>
<surname>Thurman</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Beghi</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Begley</surname>
<given-names>CE</given-names>
</string-name>, et&#x000a0;al. <article-title>Standards for epidemiologic studies and surveillance of epilepsy</article-title>. <source>Epilepsia</source>
<year>2011</year>;<volume>52</volume>(<issue>Suppl. 7</issue>):<fpage>2</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="pmid">21899536</pub-id></mixed-citation></ref><ref id="epi412020-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="epi412020-cit-0002">
<string-name>
<surname>Tellez&#x02010;Zenteno</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Hernandez&#x02010;Ronquillo</surname>
<given-names>L</given-names>
</string-name>. <article-title>A review of the epidemiology of temporal lobe epilepsy</article-title>. <source>Epilepsy Res Treat</source>
<year>2012</year>;<volume>2012</volume>:<fpage>5</fpage>.</mixed-citation></ref><ref id="epi412020-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="epi412020-cit-0003">
<string-name>
<surname>Spencer</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Huh</surname>
<given-names>L</given-names>
</string-name>. <article-title>Outcomes of epilepsy surgery in adults and children</article-title>. <source>Lancet Neurol</source>
<year>2008</year>;<volume>7</volume>:<fpage>525</fpage>&#x02013;<lpage>537</lpage>.<pub-id pub-id-type="pmid">18485316</pub-id></mixed-citation></ref><ref id="epi412020-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="epi412020-cit-0004">
<string-name>
<surname>Kujirai</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kurokawa</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kujirai</surname>
<given-names>K</given-names>
</string-name>, et&#x000a0;al. <article-title>Cortico&#x02010;cortical inhibition in focal motor cortical lesion</article-title>. <source>J Physiol</source>
<year>1995</year>;<volume>97</volume>:<fpage>S109</fpage>.</mixed-citation></ref><ref id="epi412020-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="epi412020-cit-0005">
<string-name>
<surname>Ziemann</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Reis</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Schwenkreis</surname>
<given-names>P</given-names>
</string-name>, et&#x000a0;al. <article-title>TMS and drugs revisited 2014</article-title>. <source>Clin Neurophysiol</source>
<year>2015</year>;<volume>126</volume>:<fpage>1847</fpage>&#x02013;<lpage>1868</lpage>.<pub-id pub-id-type="pmid">25534482</pub-id></mixed-citation></ref><ref id="epi412020-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="epi412020-cit-0006">
<string-name>
<surname>Badawy</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Strigaro</surname>
<given-names>G</given-names>
</string-name>. <string-name>
<surname>Cantello</surname>
<given-names>R</given-names>
</string-name>. <article-title>TMS, cortical excitability and epilepsy: the clinical impact</article-title>. <source>Epilepsy Res</source>
<year>2014</year>;<volume>108</volume>:<fpage>153</fpage>&#x02013;<lpage>161</lpage>.<pub-id pub-id-type="pmid">24315665</pub-id></mixed-citation></ref><ref id="epi412020-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="epi412020-cit-0007">
<string-name>
<surname>Schrader</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Stern</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Koski</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>Seizure incidence during single&#x02010; and paired&#x02010;pulse transcranial magnetic stimulation (TMS) in individuals with epilepsy</article-title>. <source>Clin Neurophysiol</source>
<year>2004</year>;<volume>115</volume>:<fpage>2728</fpage>&#x02013;<lpage>2737</lpage>.<pub-id pub-id-type="pmid">15546781</pub-id></mixed-citation></ref><ref id="epi412020-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="epi412020-cit-0008">
<string-name>
<surname>Hamer</surname>
<given-names>HM</given-names>
</string-name>, <string-name>
<surname>Reis</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Mueller</surname>
<given-names>HH</given-names>
</string-name>, et&#x000a0;al. <article-title>Motor cortex excitability in focal epilepsies not including the primary motor area: a TMS study</article-title>. <source>Brain</source>
<year>2005</year>;<volume>128</volume>:<fpage>811</fpage>&#x02013;<lpage>818</lpage>.<pub-id pub-id-type="pmid">15728658</pub-id></mixed-citation></ref><ref id="epi412020-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="epi412020-cit-0009">
<string-name>
<surname>Badawy</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Jackson</surname>
<given-names>GD</given-names>
</string-name>. <article-title>Cortical excitability in migraine and epilepsy: a common feature?</article-title>
<source>J Clin Neurophysiol</source>
<year>2012</year>;<volume>29</volume>:<fpage>244</fpage>&#x02013;<lpage>249</lpage>.<pub-id pub-id-type="pmid">22659718</pub-id></mixed-citation></ref><ref id="epi412020-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="epi412020-cit-0010">
<string-name>
<surname>Badawy</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Jackson</surname>
<given-names>GD</given-names>
</string-name>, <string-name>
<surname>Berkovic</surname>
<given-names>SF</given-names>
</string-name>, et&#x000a0;al. <article-title>Inter&#x02010;session repeatability of cortical excitability measurements in patients with epilepsy</article-title>. <source>Epilepsy Res</source>
<year>2012</year>;<volume>98</volume>:<fpage>182</fpage>&#x02013;<lpage>186</lpage>.<pub-id pub-id-type="pmid">22018906</pub-id></mixed-citation></ref><ref id="epi412020-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="epi412020-cit-0011">
<string-name>
<surname>Badawy</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Vogrin</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Lai</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>Cortical excitability changes correlate with fluctuations in glucose levels in patients with epilepsy</article-title>. <source>Epilepsy Behav</source>
<year>2013</year>;<volume>27</volume>:<fpage>455</fpage>&#x02013;<lpage>460</lpage>.<pub-id pub-id-type="pmid">23603690</pub-id></mixed-citation></ref><ref id="epi412020-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="epi412020-cit-0012">
<string-name>
<surname>Badawy</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Macdonell</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Berkovic</surname>
<given-names>SF</given-names>
</string-name>, et&#x000a0;al. <article-title>Predicting seizure control: cortical excitability and antiepileptic medication</article-title>. <source>Ann Neurol</source>
<year>2010</year>;<volume>67</volume>:<fpage>64</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="pmid">20186859</pub-id></mixed-citation></ref><ref id="epi412020-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="epi412020-cit-0013">
<string-name>
<surname>Badawy</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Curatolo</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Newton</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Changes in cortical excitability differentiate generalized and focal epilepsy</article-title>. <source>Ann Neurol</source>
<year>2007</year>;<volume>61</volume>:<fpage>324</fpage>&#x02013;<lpage>331</lpage>.<pub-id pub-id-type="pmid">17358004</pub-id></mixed-citation></ref><ref id="epi412020-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="epi412020-cit-0014">
<string-name>
<surname>Badawy</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Macdonell</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Jackson</surname>
<given-names>G</given-names>
</string-name>, et&#x000a0;al. <article-title>The peri&#x02010;ictal state: cortical excitability changes within 24&#x000a0;h of a seizure</article-title>. <source>Brain</source>
<year>2009</year>;<volume>132</volume>:<fpage>1013</fpage>&#x02013;<lpage>1021</lpage>.<pub-id pub-id-type="pmid">19251759</pub-id></mixed-citation></ref><ref id="epi412020-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="epi412020-cit-0015">
<string-name>
<surname>Varrasi</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Civardi</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Boccagni</surname>
<given-names>C</given-names>
</string-name>, et&#x000a0;al. <article-title>Cortical excitability in drug&#x02010;naive patients with partial epilepsy: a cross&#x02010;sectional study</article-title>. <source>Neurology</source>
<year>2004</year>;<volume>63</volume>:<fpage>2051</fpage>&#x02013;<lpage>2055</lpage>.<pub-id pub-id-type="pmid">15596749</pub-id></mixed-citation></ref><ref id="epi412020-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="epi412020-cit-0016">
<string-name>
<surname>Nitsche</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Cohen</surname>
<given-names>LG</given-names>
</string-name>, <string-name>
<surname>Wassermann</surname>
<given-names>EM</given-names>
</string-name>, et&#x000a0;al. <article-title>Transcranial direct current stimulation: state of the art 2008</article-title>. <source>Brain Stimul</source>
<year>2008</year>;<volume>1</volume>:<fpage>206</fpage>&#x02013;<lpage>223</lpage>.<pub-id pub-id-type="pmid">20633386</pub-id></mixed-citation></ref><ref id="epi412020-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="epi412020-cit-0017">
<string-name>
<surname>Bikson</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Datta</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rahman</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>Electrode montages for tDCS and weak transcranial electrical stimulation: role of &#x0201c;return&#x0201d; electrode's position and size</article-title>. <source>Clin Neurophysiol</source>
<year>2010</year>;<volume>121</volume>:<fpage>1976</fpage>&#x02013;<lpage>1978</lpage>.<pub-id pub-id-type="pmid">21035740</pub-id></mixed-citation></ref><ref id="epi412020-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="epi412020-cit-0018">
<string-name>
<surname>Gil&#x02010;Nagel</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Zaccara</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Baldinetti</surname>
<given-names>F</given-names>
</string-name>, et&#x000a0;al. <article-title>Add&#x02010;on treatment with pregabalin for partial seizures with or without generalisation: pooled data analysis of four randomised placebo&#x02010;controlled trials</article-title>. <source>Seizure</source>
<year>2009</year>;<volume>18</volume>:<fpage>184</fpage>&#x02013;<lpage>192</lpage>.<pub-id pub-id-type="pmid">18951818</pub-id></mixed-citation></ref><ref id="epi412020-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="epi412020-cit-0019">
<string-name>
<surname>Brunoni</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Amadera</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Berbel</surname>
<given-names>B</given-names>
</string-name>, et&#x000a0;al. <article-title>A systematic review on reporting and assessment of adverse effects associated with transcranial direct current stimulation</article-title>. <source>Int J Neuropsychopharmacol</source>
<year>2011</year>;<volume>14</volume>:<fpage>1133</fpage>&#x02013;<lpage>1145</lpage>.<pub-id pub-id-type="pmid">21320389</pub-id></mixed-citation></ref><ref id="epi412020-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="epi412020-cit-0020">
<string-name>
<surname>McCormick</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Contreras</surname>
<given-names>D</given-names>
</string-name>. <article-title>On the cellular and network bases of epileptic seizures</article-title>. <source>Annu Rev Physiol</source>
<year>2001</year>;<volume>63</volume>:<fpage>815</fpage>&#x02013;<lpage>846</lpage>.<pub-id pub-id-type="pmid">11181977</pub-id></mixed-citation></ref><ref id="epi412020-bib-0021"><label>21</label><mixed-citation publication-type="book" id="epi412020-cit-0021">
<string-name>
<surname>Levy</surname>
<given-names>RH</given-names>
</string-name>, <string-name>
<surname>Mattson</surname>
<given-names>RH</given-names>
</string-name>, <string-name>
<surname>Meldrum</surname>
<given-names>BS</given-names>
</string-name>, et&#x000a0;al. <source>Antiepileptic drugs</source>. <edition>5th Ed</edition>
<publisher-loc>Philadelphia, PA</publisher-loc>: <publisher-name>Lippincott Williams &#x00026; Wilkins</publisher-name>; <year>2002</year>.</mixed-citation></ref><ref id="epi412020-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="epi412020-cit-0022">
<string-name>
<surname>Liebetanz</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Nitsche</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Tergau</surname>
<given-names>F</given-names>
</string-name>, et&#x000a0;al. <article-title>Pharmacological approach to the mechanisms of transcranial DC&#x02010;stimulation&#x02010;induced aftereffects of human motor cortex excitability</article-title>. <source>Brain</source>
<year>2002</year>;<volume>125</volume>:<fpage>2238</fpage>&#x02013;<lpage>2247</lpage>.<pub-id pub-id-type="pmid">12244081</pub-id></mixed-citation></ref><ref id="epi412020-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="epi412020-cit-0023">
<string-name>
<surname>Nitsche</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Fricke</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Henschke</surname>
<given-names>U</given-names>
</string-name>, et&#x000a0;al. <article-title>Pharmacological modulation of cortical excitability shifts induced by transcranial direct current stimulation in humans</article-title>. <source>J Physiol</source>
<year>2003</year>;<volume>553</volume>:<fpage>293</fpage>&#x02013;<lpage>301</lpage>.<pub-id pub-id-type="pmid">12949224</pub-id></mixed-citation></ref><ref id="epi412020-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="epi412020-cit-0024">
<string-name>
<surname>Lang</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Nitsche</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Dileone</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Transcranial direct current stimulation effects on I&#x02010;wave activity in humans</article-title>. <source>J Neurophysiol</source>
<year>2011</year>;<volume>105</volume>:<fpage>2802</fpage>&#x02013;<lpage>2810</lpage>.<pub-id pub-id-type="pmid">21430275</pub-id></mixed-citation></ref><ref id="epi412020-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="epi412020-cit-0025">
<string-name>
<surname>Dhamne</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Ekstein</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Zhuo</surname>
<given-names>Z</given-names>
</string-name>, et&#x000a0;al. <article-title>Acute seizure suppression by transcranial direct current stimulation in rats</article-title>. <source>Ann Clin Transl Neurol</source>
<year>2015</year>;<volume>2</volume>:<fpage>843</fpage>&#x02013;<lpage>856</lpage>.<pub-id pub-id-type="pmid">26339678</pub-id></mixed-citation></ref><ref id="epi412020-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="epi412020-cit-0026">
<string-name>
<surname>George</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Aston&#x02010;Jones</surname>
<given-names>G</given-names>
</string-name>. <article-title>Noninvasive techniques for probing neurocircuitry and treating illness: vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS)</article-title>. <source>Neuropsychopharmacology</source>
<year>2010</year>;<volume>35</volume>:<fpage>301</fpage>&#x02013;<lpage>316</lpage>.<pub-id pub-id-type="pmid">19693003</pub-id></mixed-citation></ref><ref id="epi412020-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="epi412020-cit-0027">
<string-name>
<surname>Nitsche</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Paulus</surname>
<given-names>W</given-names>
</string-name>. <article-title>Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation</article-title>. <source>J Physiol</source>
<year>2000</year>;<volume>527</volume>(<issue>Pt 3</issue>):<fpage>633</fpage>&#x02013;<lpage>639</lpage>.<pub-id pub-id-type="pmid">10990547</pub-id></mixed-citation></ref><ref id="epi412020-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="epi412020-cit-0028">
<string-name>
<surname>Ferrucci</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Bortolomasi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Vergari</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Transcranial direct current stimulation in severe, drug&#x02010;resistant major depression</article-title>. <source>J Affect Disord</source>
<year>2009</year>;<volume>118</volume>:<fpage>215</fpage>&#x02013;<lpage>219</lpage>.<pub-id pub-id-type="pmid">19286265</pub-id></mixed-citation></ref><ref id="epi412020-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="epi412020-cit-0029">
<string-name>
<surname>Fregni</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Gimenes</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Valle</surname>
<given-names>AC</given-names>
</string-name>, et&#x000a0;al. <article-title>A randomized, sham&#x02010;controlled, proof of principle study of transcranial direct current stimulation for the treatment of pain in fibromyalgia</article-title>. <source>Arthritis Rheum</source>
<year>2006</year>;<volume>54</volume>:<fpage>3988</fpage>&#x02013;<lpage>3998</lpage>.<pub-id pub-id-type="pmid">17133529</pub-id></mixed-citation></ref><ref id="epi412020-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="epi412020-cit-0030">
<string-name>
<surname>Ohn</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>CI</given-names>
</string-name>, <string-name>
<surname>Yoo</surname>
<given-names>WK</given-names>
</string-name>, et&#x000a0;al. <article-title>Time&#x02010;dependent effect of transcranial direct current stimulation on the enhancement of working memory</article-title>. <source>NeuroReport</source>
<year>2008</year>;<volume>19</volume>:<fpage>43</fpage>&#x02013;<lpage>47</lpage>.<pub-id pub-id-type="pmid">18281890</pub-id></mixed-citation></ref><ref id="epi412020-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="epi412020-cit-0031">
<string-name>
<surname>Fregni</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Thome&#x02010;Souza</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Nitsche</surname>
<given-names>MA</given-names>
</string-name>, et&#x000a0;al. <article-title>A controlled clinical trial of cathodal DC polarization in patients with refractory epilepsy</article-title>. <source>Epilepsia</source>
<year>2006</year>;<volume>47</volume>:<fpage>335</fpage>&#x02013;<lpage>342</lpage>.<pub-id pub-id-type="pmid">16499758</pub-id></mixed-citation></ref><ref id="epi412020-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="epi412020-cit-0032">
<string-name>
<surname>Auvichayapat</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Rotenberg</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gersner</surname>
<given-names>R</given-names>
</string-name>, et&#x000a0;al. <article-title>Transcranial direct current stimulation for treatment of refractory childhood focal epilepsy</article-title>. <source>Brain Stimul</source>
<year>2013</year>;<volume>6</volume>:<fpage>696</fpage>&#x02013;<lpage>700</lpage>.<pub-id pub-id-type="pmid">23415937</pub-id></mixed-citation></ref><ref id="epi412020-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="epi412020-cit-0033">
<string-name>
<surname>Faria</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Fregni</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Sebastiao</surname>
<given-names>F</given-names>
</string-name>, et&#x000a0;al. <article-title>Feasibility of focal transcranial DC polarization with simultaneous EEG recording: preliminary assessment in healthy subjects and human epilepsy</article-title>. <source>Epilepsy Behav</source>
<year>2012</year>;<volume>25</volume>:<fpage>417</fpage>&#x02013;<lpage>425</lpage>.<pub-id pub-id-type="pmid">23123281</pub-id></mixed-citation></ref><ref id="epi412020-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="epi412020-cit-0034">
<string-name>
<surname>Varga</surname>
<given-names>ET</given-names>
</string-name>, <string-name>
<surname>Terney</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Atkins</surname>
<given-names>MD</given-names>
</string-name>, et&#x000a0;al. <article-title>Transcranial direct current stimulation in refractory continuous spikes and waves during slow sleep: a controlled study</article-title>. <source>Epilepsy Res</source>
<year>2011</year>;<volume>97</volume>:<fpage>142</fpage>&#x02013;<lpage>145</lpage>.<pub-id pub-id-type="pmid">21885255</pub-id></mixed-citation></ref><ref id="epi412020-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="epi412020-cit-0035">
<string-name>
<surname>Yook</surname>
<given-names>SW</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Seo</surname>
<given-names>JH</given-names>
</string-name>, et&#x000a0;al. <article-title>Suppression of seizure by cathodal transcranial direct current stimulation in an epileptic patient &#x02013; a case report</article-title>. <source>Ann Rehabil Med</source>
<year>2011</year>;<volume>35</volume>:<fpage>579</fpage>&#x02013;<lpage>582</lpage>.<pub-id pub-id-type="pmid">22506177</pub-id></mixed-citation></ref><ref id="epi412020-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="epi412020-cit-0036">
<string-name>
<surname>Liebetanz</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Koch</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Mayenfels</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Safety limits of cathodal transcranial direct current stimulation in rats</article-title>. <source>Clin Neurophysiol</source>
<year>2009</year>;<volume>120</volume>:<fpage>1161</fpage>&#x02013;<lpage>1167</lpage>.<pub-id pub-id-type="pmid">19403329</pub-id></mixed-citation></ref><ref id="epi412020-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="epi412020-cit-0037">
<string-name>
<surname>Furubayashi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Terao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Arai</surname>
<given-names>N</given-names>
</string-name>, et&#x000a0;al. <article-title>Short and long duration transcranial direct current stimulation (tDCS) over the human hand motor area</article-title>. <source>Exp Brain Res</source>
<year>2008</year>;<volume>185</volume>:<fpage>279</fpage>&#x02013;<lpage>286</lpage>.<pub-id pub-id-type="pmid">17940759</pub-id></mixed-citation></ref><ref id="epi412020-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="epi412020-cit-0038">
<string-name>
<surname>Monte&#x02010;Silva</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kuo</surname>
<given-names>MF</given-names>
</string-name>, <string-name>
<surname>Liebetanz</surname>
<given-names>D</given-names>
</string-name>, et&#x000a0;al. <article-title>Shaping the optimal repetition interval for cathodal transcranial direct current stimulation (tDCS)</article-title>. <source>J Neurophysiol</source>
<year>2010</year>;<volume>103</volume>:<fpage>1735</fpage>&#x02013;<lpage>1740</lpage>.<pub-id pub-id-type="pmid">20107115</pub-id></mixed-citation></ref><ref id="epi412020-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="epi412020-cit-0039">
<string-name>
<surname>Zoghi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>O'Brien</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Kwan</surname>
<given-names>P</given-names>
</string-name>, et&#x000a0;al. <article-title>The effects of cathodal transcranial direct current stimulation in a patient with drug&#x02010;resistant temporal lobe epilepsy (case study)</article-title>. <source>Brain Stimul</source>
<year>2016</year>;<volume>9</volume>:<fpage>790</fpage>&#x02013;<lpage>792</lpage>.<pub-id pub-id-type="pmid">27312013</pub-id></mixed-citation></ref><ref id="epi412020-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="epi412020-cit-0040">
<string-name>
<surname>San&#x02010;Juan</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Morales&#x02010;Quezada</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Orozco Garduno</surname>
<given-names>AJ</given-names>
</string-name>, et&#x000a0;al. <article-title>Transcranial direct current stimulation in epilepsy</article-title>. <source>Brain Stimul</source>
<year>2015</year>;<volume>8</volume>:<fpage>455</fpage>&#x02013;<lpage>464</lpage>.<pub-id pub-id-type="pmid">25697590</pub-id></mixed-citation></ref></ref-list></back></article>